Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chantal Housset

Showing results (61-70 of 139) with videos related to

Pageof 14
Sort By:
Journal of Hepatology|May 23, 2012
Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large populationThierry Poynard, Mona Munteanu, Olivier Deckmyn, et al.
Biochemical Pharmacology|October 22, 2008
Glycogen synthase kinase-3 inhibitors augment TRAIL-induced apoptotic death in human hepatoma cellsEléonore Beurel, Marie-José Blivet-Van Eggelpoël, Michel Kornprobst, et al.
Clinics and Research in Hepatology and Gastroenterology|March 20, 2013
Immunohistochemical profile of ezrin and radixin in human liver epithelia during fetal development and pediatric cholestatic diseasesAudrey Clapéron, Dominique Debray, Marie-José Redon, et al.
The International Journal of Biochemistry & Cell Biology|June 8, 2017
Comparison of in silico prediction and experimental assessment of ABCB4 variants identified in patients with biliary diseasesBoudour Khabou, Anne-Marie Durand-Schneider, Jean-Louis Delaunay, et al.
Hepatology (Baltimore, Md.)|September 26, 2002
Liver disease in pediatric patients with cystic fibrosis is associated with glutathione S-transferase P1 polymorphismAlexandra Henrion-Caude, Cyril Flamant, Michel Roussey, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 8, 2016
Development of an in vitro model to test antifibrotic drugs on primary human liver myofibroblastsLynda Aoudjehane, Pierre-Yves Boelle, Grégoire Bisch, et al.
Hepatology (Baltimore, Md.)|January 22, 2005
Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosisEduardo Schiffer, Chantal Housset, Wulfran Cacheux, et al.
Journal of Hepatology|January 25, 2005
Adaptative bile duct proliferative response in experimental bile duct ischemiaMarc Beaussier, Dominique Wendum, Laura Fouassier, et al.
BMC Gastroenterology|April 16, 2011
Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of ageThierry Poynard, Mona Munteanu, Olivier Deckmyn, et al.
The Journal of Biological Chemistry|December 21, 2011
Effects of cellular, chemical, and pharmacological chaperones on the rescue of a trafficking-defective mutant of the ATP-binding cassette transporter proteins ABCB1/ABCB4Julien Gautherot, Anne-Marie Durand-Schneider, Danièle Delautier, et al.
Pageof 14

Showing results (61-70 of 139) with videos related to

Sort By:
Pageof 14
Journal of Hepatology|May 23, 2012
Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large populationThierry Poynard, Mona Munteanu, Olivier Deckmyn, et al.
Biochemical Pharmacology|October 22, 2008
Glycogen synthase kinase-3 inhibitors augment TRAIL-induced apoptotic death in human hepatoma cellsEléonore Beurel, Marie-José Blivet-Van Eggelpoël, Michel Kornprobst, et al.
Clinics and Research in Hepatology and Gastroenterology|March 20, 2013
Immunohistochemical profile of ezrin and radixin in human liver epithelia during fetal development and pediatric cholestatic diseasesAudrey Clapéron, Dominique Debray, Marie-José Redon, et al.
The International Journal of Biochemistry & Cell Biology|June 8, 2017
Comparison of in silico prediction and experimental assessment of ABCB4 variants identified in patients with biliary diseasesBoudour Khabou, Anne-Marie Durand-Schneider, Jean-Louis Delaunay, et al.
Hepatology (Baltimore, Md.)|September 26, 2002
Liver disease in pediatric patients with cystic fibrosis is associated with glutathione S-transferase P1 polymorphismAlexandra Henrion-Caude, Cyril Flamant, Michel Roussey, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 8, 2016
Development of an in vitro model to test antifibrotic drugs on primary human liver myofibroblastsLynda Aoudjehane, Pierre-Yves Boelle, Grégoire Bisch, et al.
Hepatology (Baltimore, Md.)|January 22, 2005
Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosisEduardo Schiffer, Chantal Housset, Wulfran Cacheux, et al.
Journal of Hepatology|January 25, 2005
Adaptative bile duct proliferative response in experimental bile duct ischemiaMarc Beaussier, Dominique Wendum, Laura Fouassier, et al.
BMC Gastroenterology|April 16, 2011
Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of ageThierry Poynard, Mona Munteanu, Olivier Deckmyn, et al.
The Journal of Biological Chemistry|December 21, 2011
Effects of cellular, chemical, and pharmacological chaperones on the rescue of a trafficking-defective mutant of the ATP-binding cassette transporter proteins ABCB1/ABCB4Julien Gautherot, Anne-Marie Durand-Schneider, Danièle Delautier, et al.
Pageof 14